Overview Research Programs Shared Facilities News & Outreach Technology Transfer Employment About PHRI


  World TB Day: Thursday, March 24, 2016

KochMarch 24, 2016, was World Tuberculosis Day (TB Day). On March 24, 1882, Dr. Robert Koch announced the discovery of Mycobacterium tuberculosis, the bacterium that causes tuberculosis (TB). During this time, TB killed one out of every seven people living in the United States and Europe. Dr. Koch’s discovery was the most important step taken toward the control and elimination of this deadly disease. In 1982, a century after Dr. Koch's announcement, the first World TB Day was sponsored by the World Health Organization (WHO) and the International Union Against Tuberculosis and Lung Disease (IUATLD). The event was intended to educate the public about the devastating health and economic consequences of TB, its effect on developing countries, and its continued tragic impact on global health. Today, World TB Day is commemorated across the globe, but more must be done to raise awareness about the effects of TB. Among infectious diseases, TB remains the second leading killer of adults in the world, with approximately1.5 million TB-related deaths in 2013. Until TB is controlled, World TB Day won’t be a celebration, but it is a valuable opportunity to educate the public about the devastation TB can spread and how it can be stopped. PHRI has a long history of research on the research and clinical aspects of TB. This year, several faculty members from PHRI and other departments at the New Jersey Medical School participated in the World TB Day symposium that was held on March 31 and April 1. This event was hosted at PHRI.

Follow this link to download a PDF copy of the World TB Day Symposium Agenda

A history on Tuberculosis research at PHRI can be read in the following PDF document

Faculty Positions Infectious Diseases Research

The Public Health Research Institute (PHRI) of New Jersey Medical School - Rutgers University located in Newark, New Jersey, is recruiting a new faculty member at the middle or senior levels to join a growing group of 23 laboratories. PHRI is a leading infectious diseases research center that emphasizes basic and translational sciences. Candidates must have training and experience of the highest quality, and a NIH funded research program addressing critical questions in cell biology, immunology and molecular biology that offer novel insights into pathogenicity, as well as innovative approaches for new vaccines, therapeutics and diagnostics. The PHRI Center is housed in a state of the art research facility that has extensive core services, including nationally designated BL3 laboratory and animal facilities, X-ray facility for structural studies and applied genomics center. The PHRI Center offers a robust and highly collegial research environment, generous start-up funds, and a comprehensive benefits package. Candidates should submit a curriculum vitae, a statement of research interests and accomplishments and a list of at least three references.

Any questions or applications should be sent to: Dr. Barry Kreiswirth, Public Health Research Institute, Rutgers, New Jersey Medical School, 225 Warren Street, Newark, NJ 07103. Telephone: (973) 854-3240. Fax: (973) 854-3101. Email: kreiswba@njms.rutgers.edu

Please note that effective July 1, 2013, as a result of the New Jersey Medical and Health Sciences Restructuring Act, several units from the former University of Medicine and Dentistry of New Jersey (UMDNJ) are now part of Rutgers Biomedical and Health Sciences (RBHS). For the purposes of payroll and benefits administration, the above position is a legacy UMDNJ position at Rutgers, and is eligible for benefits associated with legacy UMDNJ positions.

The PHRI is an Equal Opportunity Employer.

To download a PDF copy of this employment opportunity advertisement, which appeared in the February 7, 2014, issue of Science click here

  07.01.16   www.nytimes.com: As experts confront the hazards of Zika, fear and uncertainty hover
  07.01.16   www.cdc.gov: Clinical alert to U.S. healthcare facilities: Global emergence of invasive infections caused by the multidrug-resistant yeast Candida auris
  05.27.16   www.msn.com: The superbug that doctors have been dreading just reached the U.S.
  05.24.16   www.nejm.com: Special Report: Zika Virus and Birth Defects — Reviewing the Evidence for Causality
  05.24.16   www.msn.com: Your keyboard could be harboring dangerous bacteria — here’s how to clean it
  02.09.16   www.mdlinx.com: Obama requests emergency funding to combat Zika

  07.08.16   This month's Paper Highlights features three publications by Selvakumar Subbian's group of wich one study was carried out in collaboration with Lanbo Shi and Eliseo Eugenina. For details, please visit PHRI Paper Highlights
  06.20.16   At ASM Microbe 2016, which was held in Boston, MA. from June 16 - June 20, a recent publication by Dr. Kelly Healey (a Postdoctoral fellow in Dr. David Perlin’s laboratory) in Nature Communications on a mutator genotype that promotes multi-drug resistance in the fungal pathogen Candida glabrata was voted this year’s top article in Medical Mycology. The article is featured in PHRI Paper Highlights
  06.08.16   June's Paper Highlights features a publication by Diana Vargas, Fred Kramer, Sanjay Tyagi and Salvatore Marras, published in PLoS ONE. They describe the use of “SuperSelective” primers that enable the detection and quantitation of somatic mutations whose presence relates to cancer diagnosis, prognosis, and therapy, in real-time multiplex PCR assays that can potentially analyze rare DNA fragments present in blood samples (liquid biopsies). For details, please visit PHRI Paper Highlights In addition, GenomeWeb published an interview with Fred Kramer, in which he describes the technology. Follow this link to download a PDF copy of the interview.
  04.26.16   A postdoctoral position is available at PHRI, in the laboratory of Dr. Selvakumar Subbian. For details, visit Employment Opportunities
  03.15.16   Together with the Global Tuberculosis Institute and the New Jersey Department of Health, Public Health Research Institute co-sponsors the 2016 World Tuberculosis Day Symposium. PHRI Faculty members Drs. Barry Kreiswirth and Marila Gennaro are among the speakers who present their work to discuss current concepts in clinical care and translational science. For details and registration, visit www.globaltb.njms.rutgers.edu
  02.18.16   The WInter 2016 issue of Rutgers Magazine features an article discussing a new highly sensitive diagnostic assay to detect Lyme disease that PHRI Faculty Dr. Salvatore Marras co-developed with Dr. Nikhat Parveen at NJMS. To read the article, please visit www.magazine.rutgers.edu



Follow us on:    
     Copyright © 2016 All rights reserved.   PHRI at ICPH 225 Warren St. Newark, NJ 07103-3535 TEL 973 854 3100, FAX 973 854 3101